Concepedia

Lorenz Buser

LB

11

Publications

626

Citations

10

H-Index

2009

Active since

Affiliations

University Hospital of Zurich(Current)

University of Zurich

ETH Zurich

University Hospital of Basel

Université Paris Cité

Lorenz Buser is an author at University Hospital of Zurich specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

2009–2023

11

Publications

11

Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

Xiangpeng Dai, Wenjian Gan, Xiaoning Li et al. · Nature Medicine · 2017 · 333 citations · Full text

, , +6

Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study

Mihael Potocki, Tobias Breidthardt, Tobias Reichlin et al. · Critical Care · 2009 · 52 citations · Full text

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

Cédric Poyet, Lorenz Buser, Filip Roudnicky et al. · Journal of Clinical Pathology · 2015 · 43 citations · Full text

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Charlotte S. Voskuilen, Htoo Zarni Oo, Vera Genitsch et al. · The American Journal of Surgical Pathology · 2019 · 43 citations

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer

Marian S. Wettstein, Lorenz Buser, Thomas Hermanns et al. · Disease Markers · 2015 · 42 citations · Full text

Rows per page

1–5 of 11